SANFORD H. ROTH, M.D.
This content is PDF only. Please click on the PDF icon to access.
To the editor: The Food and Drug Administration (FDA) has just reported the completion of the first revision of guidelines for the clinical evaluation of nonsteroidal anti-inflammatory and antirheumatic drugs (for adults and children) since the guidelines were first proposed in 1967. This marks the culmination of a unique ad hoc group interaction of the FDA, industry, and academic departments of rheumatology and is the result of an ongoing series of extramural meetings previously reported in Annals (1, 2). This document, when published, will provide updated guidelines for more efficient and statistically appropriate assessment of anti-inflammatory drugs and, for the
ROTH SH. Evaluating the Antirheumatic Drugs. Ann Intern Med. 1986;105:632. doi: https://doi.org/10.7326/0003-4819-105-4-632_2
Download citation file:
Published: Ann Intern Med. 1986;105(4):632.
Copyright © 2020 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use